Seaport Therapeutics
Operator of a biopharmaceutical company intended to develop novel neuropsychiatric medicines in areas of patient need. The company's medicines offer oral bioavailability, bypassing first-pass metaboli...
Valuation
$740M
Latest known
Share Price
N/A
Total Raised
$329.9M
Last Round
N/A